Media coverage
9
Media coverage
Title United Therapeutics continues to outperform Gilead Media name/outlet Global Round Up - Sectors Country/Territory United Kingdom Date 4/1/24 Persons Judith Klein-Seetharaman Title United Therapeutics continues to outperform Amgen Media name/outlet Global Round Up - Sectors Country/Territory United Kingdom Date 4/1/24 Persons Judith Klein-Seetharaman Title United Therapeutics continues to outperform Regeneron Media name/outlet Global Round Up - Sectors Country/Territory United Kingdom Date 4/1/24 Persons Judith Klein-Seetharaman Title United Therapeutics continues to outperform Vertex Pharmaceuticals Media name/outlet Global Round Up - Sectors Country/Territory United Kingdom Date 4/1/24 Persons Judith Klein-Seetharaman Title United Therapeutics's Earnings Growth Lags Gilead Media name/outlet Global Round Up - Sectors Country/Territory United Kingdom Date 4/1/24 Persons Judith Klein-Seetharaman Title United Therapeutics's Earnings Growth Lags Regeneron Media name/outlet Global Round Up - Sectors Country/Territory United Kingdom Date 4/1/24 Persons Judith Klein-Seetharaman Title United Therapeutics's Earnings Growth Lags Vertex Pharmaceuticals Media name/outlet Global Round Up - Sectors Country/Territory United Kingdom Date 4/1/24 Persons Judith Klein-Seetharaman Title United Therapeutics's Earnings Growth Lags Amgen Media name/outlet Global Round Up - Sectors Country/Territory United Kingdom Date 4/1/24 Persons Judith Klein-Seetharaman Title United Therapeutics- 7 Reasons Investors Remain Bullish (and 1 Reason Why Bearish) Media name/outlet Global Round Up - Sectors Country/Territory United Kingdom Date 4/1/24 Persons Judith Klein-Seetharaman